Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing

IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Xianjin Luo , Janin Germer , Tobias Burghardt , Melina Grau , Yi Lin , Miriam Höhn , Ulrich Lächelt , Ernst Wagner
{"title":"Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing","authors":"Xianjin Luo ,&nbsp;Janin Germer ,&nbsp;Tobias Burghardt ,&nbsp;Melina Grau ,&nbsp;Yi Lin ,&nbsp;Miriam Höhn ,&nbsp;Ulrich Lächelt ,&nbsp;Ernst Wagner","doi":"10.1016/j.ejps.2024.106983","DOIUrl":null,"url":null,"abstract":"<div><div>Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR associated (Cas) protein has been proved as a powerful tool for the treatment of genetic diseases. The Cas9 protein, when combined with single-guide RNA (sgRNA), forms a Cas9/sgRNA ribonucleoprotein (RNP) capable of targeting and editing the genome. However, the limited availability of effective carriers has restricted the broader application of CRISPR/Cas9 RNP. In this study, we evaluated dual pH-responsive amphiphilic xenopeptides (XPs) for delivering CRISPR/Cas9 RNP. These artificial lipo-XPs contain apolar cationizable lipoamino fatty acid (LAF) and polar cationizable oligoaminoethylene acid units such as succinoyl-tetraethylenepentamine (Stp) in various ratios and U-shaped topologies. The carriers were screened for functional Cas9/sgRNA RNP delivery in four different reporter cell lines, including a Duchenne muscular dystrophy (DMD) exon skipping reporter cell model. Significantly enhanced cellular uptake into HeLa cells, effective endosomal disruption in HeLa gal8-mRuby3 cells, and potent genome editing by several Cas9/sgRNA RNP complexes was observed in four different cell lines in the 5 nM sgRNA range. Comparing Cas9/sgRNA RNP complexes with Cas9 mRNA/sgRNA polyplexes in the DMD reporter cell model demonstrated similar splice site editing and high exon skipping of the two different molecular Cas9 modalities. Based on these studies, analogues of two potent U1 LAF<sub>2</sub>-Stp and LAF<sub>4</sub>-Stp<sub>2</sub> structures were deployed, tuning the amphiphilicity of the polar Stp group by replacement with the six oligoamino acids dmGtp, chGtp, dGtp, Htp, Stt, or GEIPA. The most potent LAF<sub>2</sub>-Stp analogues (containing dGtp, chGtp or GEIPA) demonstrated further enhanced gene editing efficiency with EC50 values of 1 nM in the DMD exon skipping reporter cell line. Notably, the EC50 of LAF<sub>2</sub>-dGtp reached 0.51 nM even upon serum incubation. Another carrier (LAF<sub>4</sub>-GEIPA<sub>2</sub>) complexing Cas9/sgRNA RNP and donor DNA, facilitated up to 43 % of homology-directed repair (HDR) in HeLa eGFPd2 cells visualized by the switch from green fluorescent protein (eGFP) to blue fluorescent protein (BFP). This study presents a delivery system tunable for Cas9 RNP complexes or Cas9 RNP/donor DNA polyplexes, offering an effective and easily applicable strategy for gene editing.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"205 ","pages":"Article 106983"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098724002963","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR associated (Cas) protein has been proved as a powerful tool for the treatment of genetic diseases. The Cas9 protein, when combined with single-guide RNA (sgRNA), forms a Cas9/sgRNA ribonucleoprotein (RNP) capable of targeting and editing the genome. However, the limited availability of effective carriers has restricted the broader application of CRISPR/Cas9 RNP. In this study, we evaluated dual pH-responsive amphiphilic xenopeptides (XPs) for delivering CRISPR/Cas9 RNP. These artificial lipo-XPs contain apolar cationizable lipoamino fatty acid (LAF) and polar cationizable oligoaminoethylene acid units such as succinoyl-tetraethylenepentamine (Stp) in various ratios and U-shaped topologies. The carriers were screened for functional Cas9/sgRNA RNP delivery in four different reporter cell lines, including a Duchenne muscular dystrophy (DMD) exon skipping reporter cell model. Significantly enhanced cellular uptake into HeLa cells, effective endosomal disruption in HeLa gal8-mRuby3 cells, and potent genome editing by several Cas9/sgRNA RNP complexes was observed in four different cell lines in the 5 nM sgRNA range. Comparing Cas9/sgRNA RNP complexes with Cas9 mRNA/sgRNA polyplexes in the DMD reporter cell model demonstrated similar splice site editing and high exon skipping of the two different molecular Cas9 modalities. Based on these studies, analogues of two potent U1 LAF2-Stp and LAF4-Stp2 structures were deployed, tuning the amphiphilicity of the polar Stp group by replacement with the six oligoamino acids dmGtp, chGtp, dGtp, Htp, Stt, or GEIPA. The most potent LAF2-Stp analogues (containing dGtp, chGtp or GEIPA) demonstrated further enhanced gene editing efficiency with EC50 values of 1 nM in the DMD exon skipping reporter cell line. Notably, the EC50 of LAF2-dGtp reached 0.51 nM even upon serum incubation. Another carrier (LAF4-GEIPA2) complexing Cas9/sgRNA RNP and donor DNA, facilitated up to 43 % of homology-directed repair (HDR) in HeLa eGFPd2 cells visualized by the switch from green fluorescent protein (eGFP) to blue fluorescent protein (BFP). This study presents a delivery system tunable for Cas9 RNP complexes or Cas9 RNP/donor DNA polyplexes, offering an effective and easily applicable strategy for gene editing.

Abstract Image

用于基因组编辑的双ph响应CRISPR/Cas9核糖核蛋白外肽复合物。
聚类规则间隔短回文重复(CRISPR)/CRISPR相关(Cas)蛋白已被证明是治疗遗传性疾病的有力工具。Cas9蛋白与单导RNA (sgRNA)结合,形成Cas9/sgRNA核糖核蛋白(RNP),能够靶向和编辑基因组。然而,有效载体的有限可用性限制了CRISPR/Cas9 RNP的广泛应用。在这项研究中,我们评估了双ph响应性两亲性外肽(XPs)递送CRISPR/Cas9 RNP的作用。这些人造脂质xps含有极性阳离子化脂氨基脂肪酸(LAF)和极性阳离子化低氨基乙烯单位,如琥珀酰四乙基戊二胺(Stp),其比例和结构呈u形。这些载体在四种不同的报告细胞系中进行了Cas9/sgRNA RNP递送功能筛选,包括杜氏肌营养不良(DMD)外显子跳跃报告细胞模型。在4种不同的细胞系中,在5 nM sgRNA范围内观察到显著增强HeLa细胞的细胞摄取,有效地破坏HeLa gal8-mRuby3细胞的内体,以及几种Cas9/sgRNA RNP复合物的有效基因组编辑。将DMD报告细胞模型中的Cas9/sgRNA RNP复合物与Cas9 mRNA/sgRNA多plex进行比较,发现两种不同的Cas9分子模式具有相似的剪接位点编辑和高外显子跳变。在这些研究的基础上,研究人员部署了两种有效的U1 LAF2-Stp和LAF4-Stp2结构的类似物,通过替换6个低聚氨基酸dmGtp、chGtp、dGtp、Htp、Stt或GEIPA来调整极性Stp基团的两亲性。最有效的LAF2-Stp类似物(含有dGtp、chGtp或GEIPA)在DMD外显子跳变报告细胞系中显示出进一步增强的基因编辑效率,EC50值为1 nM。值得注意的是,即使在血清孵育后,LAF2-dGtp的EC50也达到了0.51 nM。另一种载体(LAF4-GEIPA2)络合Cas9/sgRNA RNP和供体DNA,在HeLa eGFPd2细胞中促进了高达43%的同源定向修复(HDR),通过绿色荧光蛋白(eGFP)向蓝色荧光蛋白(BFP)的转换可见。本研究提出了一种可调节Cas9 RNP复合物或Cas9 RNP/供体DNA多聚体的递送系统,为基因编辑提供了一种有效且易于应用的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信